Paclitaxel: all 2,138 studies that test it
Page 18 of 22. Open to participants first (342), then studies with results posted, then the rest; newest registration first within each.
- Study of Combination Therapy of Carboplatin -Gemcitabine Plus Bevacizumab Beyond Progression in Patients With Locally Advanced and/or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Not Received Prior Systemic TherapyCompletedNCT00702975Phase 2
- Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung CancerTerminatedNCT00702572Phase 1
- Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal DoxorubicinTerminatedNCT00691912Phase 2
- Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast CancerCompletedNCT00691379Phase 1/2
- Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung CancerCompletedNCT00687817Phase 2
- Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine CarcinosarcomaCompletedNCT00687687Phase 2
- Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)CompletedNCT00686322Phase 4
- Single Agent Abraxane as Second Line Therapy in Bladder CancerCompletedNCT00683059Phase 2
- Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast CancerCompletedNCT00680758Phase 1
- Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph NodesCompletedNCT00668616Phase 3
- Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsCompletedNCT00667641Phase 1
- Phase II Study of ABI-007 for Gastric CancerCompletedNCT00661167Phase 2
- Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free IntervalStatus unknownNCT00657878Phase 3
- Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian OriginStatus unknownNCT00652119Phase 1
- Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric CarcinomaStatus unknownNCT00639522Phase 1
- Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)CompletedNCT00625573Phase 2
- Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: FeasibilityCompletedNCT00617370Not applicable
- Paclitaxel and Carboplatin With or Without Nitroglycerin in Treating Patients With Previously Untreated Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT00616031Phase 2
- Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinCompletedNCT00611962Phase 2
- A Phase II Study Of Abraxane and Nexavar in the First-Line Treatment of Locally Advanced or Metastatic Breast CancerTerminatedNCT00607438Phase 2
- Pharmacokinetics Study of Liposomal Paclitaxel in HumansCompletedNCT00606515Phase 4
- Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung CancerCompletedNCT00578149Phase 2
- Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial CancerCompletedNCT00575952Phase 1
- Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast CancerCompletedNCT00567554Phase 3
- Maintenance Versus Observation After 6 Cycles of Gemcitabine Plus Paclitaxel in Pts With Advanced Breast CancerCompletedNCT00561119Phase 3
- LBH589, Paclitaxel, Carboplatin +/- Bevacizumab for Solid TumorsCompletedNCT00556088Phase 1
- Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell TumorsStatus unknownNCT00551122Phase 1/2
- Combination Chemotherapy and Autologous Peripheral Stem Cell Transplant in Treating Patients With Stage III, Stage IV, or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00550784Phase 1
- Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE)CompletedNCT00544232Phase 3
- Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast CancerStatus unknownNCT00538395Not applicable
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid CancerCompletedNCT00535119Phase 1
- BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00533585Phase 1
- Phase II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and TrastuzumabCompletedNCT00532857Phase 2
- Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell CancerTerminatedNCT00531687Phase 2
- Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in MelanomaTerminatedNCT00522834Phase 3
- Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate CancerTerminatedNCT00521781Phase 2
- Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT00520000Phase 1
- Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This QuestionnaireCompletedNCT00517621Phase 2
- Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or PaclitaxelCompletedNCT00516724Phase 1
- Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver InvolvementCompletedNCT00508326Phase 1
- Malignant Mixed Mesodermal Tumor (MMMT) - Early Stage With Postoperative XRT/ChemotherapyTerminatedNCT00505492Phase 2
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWithdrawnNCT00499291Not applicable
- Phase I Study in Patients With Solid TumoursCompletedNCT00496028Phase 1
- Sorafenib in Combination With Carboplatin and Paclitaxel in Treating Participants With Metastatic or Recurrent Head and Neck Squamous Cell CancerActive, not recruitingNCT00494182Phase 2
- Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal CarcinomatosisCompletedNCT00491855Phase 1
- Treatment of Paclitaxel Plus Carboplatin Followed by Gemcitabine Plus Carboplatin for Patients With Epithelial Ovarian CancerCompletedNCT00490711Phase 2
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity CancerCompletedNCT00483782Phase 3
- A Phase II Trial OF Carboplatin, ABI-007 (Abraxane) And Sorafenib (BAY 43-9006) in Metastatic MelanomaCompletedNCT00483301Phase 2
- Phase I Study of the Combination of Satraplatin and Abraxane in Advanced CancersCompletedNCT00473720Phase 1
- Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast CancerCompletedNCT00472693Phase 2
- Phase Ⅱ Clinical Study of R435 (Bevacizumab) in Combination With Paclitaxel in Patients With Inoperable Metastatic Breast CancerCompletedNCT00467012Phase 2
- Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian CancerCompletedNCT00466986Phase 2
- Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung CancerTerminatedNCT00465907Phase 2
- Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical CancerStatus unknownNCT00462397Phase 2
- Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary TumorWithdrawnNCT00458315Phase 2
- Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal CancerStatus unknownNCT00453323Phase 2
- Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung CancerCompletedNCT00453167Phase 2
- Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLCTerminatedNCT00449657Phase 2
- EndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsCompletedNCT00448305Phase 2
- Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast CancerStatus unknownNCT00436709Not applicable
- Alimta and Gemcitabine in Non-Small Cell Lung CancerCompletedNCT00434135Phase 2
- Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast CancerActive, not recruitingNCT00433420Phase 3
- Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast CancerCompletedNCT00431080Phase 3
- A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid TumorsCompletedNCT00422682Phase 1
- Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial CancerActive, not recruitingNCT00411138Phase 3
- Abraxane and Temodar Plus Genasense in Advanced MelanomaStatus unknownNCT00409383Phase 1
- Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00408655Phase 1
- ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CarcinomaTerminatedNCT00407407Phase 1
- MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian CancerCompletedNCT00401674Phase 2
- Phase I Trial of Paclitaxel With PerifosineCompletedNCT00399126Phase 1
- Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast CancerWithdrawnNCT00397761Phase 2/3
- Pazopanib (VOTRIENT) Plus Paclitaxel (TAXOL), Pazopanib Plus Paclitaxel (TAXOL) Plus Carboplatin (PARAPLATIN), and Pazopanib Plus Paclitaxel (TAXOL) Plus Lapatinib (TYKERB)CompletedNCT00388076Phase 1
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
- A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast CancerCompletedNCT00378313Phase 2
- A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer PatientsStatus unknownNCT00373620Phase 2
- Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
- Trial of PTK787/ZK 222584 Plus PaclitaxelTerminatedNCT00358163Phase 1
- Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerCompletedNCT00352300Phase 1
- Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal CancerCompletedNCT00344552Phase 2
- A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer PatientsCompletedNCT00340184Phase 2
- A Phase II Trial Neoadjuvant Paclitaxel and Cisplatin in Patients With Locally Advanced Head and Neck CancerCompletedNCT00337532Phase 2/3
- A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid CancersTerminatedNCT00337376Phase 1
- Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast CancerCompletedNCT00336791Phase 3
- Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00334763Phase 2
- Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer PatientsCompletedNCT00334321Phase 1
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast CancerCompletedNCT00322400Phase 1
- A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung CancerCompletedNCT00317200Phase 2
- Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer PatientsCompletedNCT00316407Phase 1/2
- Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal CancerCompletedNCT00314678Phase 2
- Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCTerminatedNCT00313768Phase 2
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the UrotheliumCompletedNCT00310011Phase 2
- Dose Dense Abraxane in Adjuvant Chemotherapy for Breast CancerCompletedNCT00308178Not applicable
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine in Treating Patients With Advanced Metastatic Solid TumorsCompletedNCT00307255Phase 1
- Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00298415Phase 3
- Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLCTerminatedNCT00291850Phase 2
- Maintenance Chemotherapy in Metastatic Breast CancerStatus unknownNCT00289263Phase 3
- Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic MelanomaCompletedNCT00288041Phase 2
- Vorinostat, Paclitaxel, and Carboplatin in Treating Patients With Advanced or Refractory Solid TumorsCompletedNCT00287937Phase 1